Inventor · disambiguated record
Wenlang Fu
Also filed as: FU WENLANG
11 granted patents·7 pending applications·50 citations·filing 2002–2021
86Inventor score
Files withBAYER PHARMACEUTICALS CORP5BAYER HEALTHCARE LLC3MERCK SHARP & DOHME LLC3BUTORA GABOR1DIXON JULIE A1
Top patents by PatentIndex Score
18 records- 0190US8877439B2Method for rapidly evaluating performance of short interfering RNA with novel chemical modificationsBUTORA GABOR·Filed 2010·Granted Nov 4, 2014·22 cites·18 claims
- 0288US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 0385US7678804B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER HEALTHCARE LLC·Filed 2005·Granted Mar 16, 2010·4 cites·11 claims
- 0479US9512426B2Method for rapidly evaluating performance of short interfering RNA with novel chemical modificationsSIRNA THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·2 cites·18 claims
- 0578US10450335B2Antiviral oxime phosphoramide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Oct 22, 2019·3 cites·26 claims
- 0670US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 0767US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 0862US8338595B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Dec 25, 2012·0 cites·8 claims
- 0961US9040691B2Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitorsKLAR JÜRGEN·Filed 2012·Granted May 26, 2015·1 cites·8 claims
- 1056US12454525B2IL4I1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 28, 2025·0 cites·25 claims
- 1155US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 1253US2013225809A1Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
- 1351US12304899B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 20, 2025·0 cites·13 claims
- 1445US2011195110A1Urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2006·Application pending·0 cites
- 1543US2011098301A1Pyrimidine Derivatives for Treatment of Hyperproliferative DisordersBAYER HEALTHCARE LLC·Filed 2006·Application pending·0 cites
- 1643US2009258888A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 1743US2009286785A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 1837US2004267017A13-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenlang Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →